Evidence map›Paper›PMID 41168500›Full record

ArticleOncogene2025

Correction: Non-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution.

Gal Twito, Faiza Amterat Abu Abayed, Ayelet Gilad, Suma Biadsy, Noa Gavriel, Suad Sheikh Suliman, Yarden Mizrahi, Hila Megged, Mor Tenenboim, Naim Abu-Freha and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Gal TwitoDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.ORCID http://orcid.org/0009-0003-8234-317X
Faiza Amterat Abu AbayedDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Ayelet GiladDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Suma BiadsyDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Noa GavrielDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Suad Sheikh SulimanDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Yarden MizrahiDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Hila MeggedDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Mor TenenboimDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Naim Abu-FrehaInstitute of Gastroenterology and Liver Diseases, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Aeid IgbariaDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. aigbaria@bgu.ac.il.ORCID http://orcid.org/0000-0003-3940-1824

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41168500
PMCPMC12623230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.